Sign in to view content

New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases

Alay S. Banker, MD

Video
Published 2018

Related

LADDER Trial of the Port Delivery System with Ranibizumab: Initial Study Results
Carl C. Awh, MD, FASRS
Annual Meeting Talks
2018
Intravitreal Anti-VEGF Injections for Exudative Retinal Arterial Macroaneurysms: Results of an International Multicenter Study
J. Fernando Arevalo, MD, PhD, FACS, FASRS
Annual Meeting Talks
2020
Vitreous Biomarkers for Alzheimer’s Disease in Patients Undergoing Vitrectomy and Cognitive Function Assessment
Manju L. Subramanian, MD
Annual Meeting Talks
2018

Category: Retinal Vascular Disease

See more